Literature DB >> 11726732

Physical growth and retinopathy in preterm infants: involvement of IGF-I and GH.

S Hikino1, K Ihara, J Yamamoto, Y Takahata, H Nakayama, N Kinukawa, Y Narazaki, T Hara.   

Abstract

GH and IGF-I are important for physical growth. We measured serum levels of these factors in preterm infants. The study population (n = 81) was divided into three groups according to the gestational age. We evaluated differences in serum GH and IGF-I levels among groups with regard to physical growth and development of retinopathy of prematurity. Serum GH levels in extremely preterm infants born at <28 wk of gestational age were significantly higher than levels in those born between 28 and 34 wk at 1 and 2 mo of age. In contrast, serum IGF-I levels in extremely preterm infants remained low, whereas those in the other two groups gradually increased. Evaluation of the effects of GH and IGF-I on physical growth in very low birth weight infants (<1500 g) showed that IGF-I concentrations were positively related to physical growth for several months after birth, whereas no relationship was observed between GH and physical growth. Multivariate analysis demonstrated that high GH concentration at 1 mo of age was significantly associated with development of severe retinopathy of prematurity. In conclusion, persistent low serum IGF-I levels may explain the slow physical growth during neonatal life, and exposure of high GH may cause, at least in part, severe retinopathy of prematurity in preterm infants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726732     DOI: 10.1203/00006450-200112000-00017

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

1.  The role of serum insulin-like growth factor I (IGF-I) in neonatal outcome.

Authors:  A R Hayati; F C Cheah; J F Yong; A E Tan; W M Norizah
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

2.  A clinical prediction model to stratify retinopathy of prematurity risk using postnatal weight gain.

Authors:  Gil Binenbaum; Gui-shuang Ying; Graham E Quinn; Stephan Dreiseitl; Karen Karp; Robin S Roberts; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-02-14       Impact factor: 7.124

3.  Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety.

Authors:  David Ley; Ingrid Hansen-Pupp; Aimon Niklasson; Magnus Domellöf; Lena E Friberg; Jan Borg; Chatarina Löfqvist; Gunnel Hellgren; Lois E H Smith; Anna-Lena Hård; Ann Hellström
Journal:  Pediatr Res       Date:  2012-10-24       Impact factor: 3.756

Review 4.  Algorithms for the prediction of retinopathy of prematurity based on postnatal weight gain.

Authors:  Gil Binenbaum
Journal:  Clin Perinatol       Date:  2013-06       Impact factor: 3.430

5.  A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants.

Authors:  Chatarina Löfqvist; Aimon Niklasson; Eva Engström; Lena E Friberg; Cecilia Camacho-Hübner; David Ley; Jan Borg; Lois E H Smith; Ann Hellström
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

6.  IGF-I and relation to growth in infancy and early childhood in very-low-birth-weight infants and term born infants.

Authors:  Miranda de Jong; Anneke Cranendonk; Jos W R Twisk; Mirjam M van Weissenbruch
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

7.  Time to regain birth weight - a marker to predict the severity of retinopathy of prematurity?

Authors:  Ajay Anvekar; Sam Athikarisamy; Shripada Rao; Andy Gill; Elizabeth Nathan; Dorota Doherty; Geoffrey Lam
Journal:  BMC Pediatr       Date:  2021-12-02       Impact factor: 2.125

8.  Early nutrition and weight gain in preterm newborns and the risk of retinopathy of prematurity.

Authors:  Deborah K VanderVeen; Camilia R Martin; Reshma Mehendale; Elizabeth N Allred; Olaf Dammann; Alan Leviton
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

9.  A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe).

Authors:  Kathryn Beardsall; Sophie Vanhaesebrouck; Amanda L Ogilvy-Stuart; Jag S Ahluwalia; Christine Vanhole; Christopher Palmer; Paula Midgley; Mike Thompson; Luc Cornette; Mirjam Weissenbruch; Marta Thio; Francis de Zegher; David Dunger
Journal:  BMC Pediatr       Date:  2007-08-10       Impact factor: 2.125

10.  Neonatal growth and breast cancer risk in adulthood.

Authors:  P Lagiou; C-C Hsieh; D Trichopoulos; H-O Adami; P Hall; L Chie; A Ekbom
Journal:  Br J Cancer       Date:  2008-09-30       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.